Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin

Fertility and Sterility

Volumn 73, Issue 3, 2000, Pages 536-540

  Stricker, Raphael B ^a   Steinleitner, Alex ^b   Bookoff, Charles N ^a   Weckstein, Louis N ^c   Winger, Edward E ^d  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b Astarte Medical Group   (United States)

^c Reproductive Science Center   (United States)

^d Immunodiagnostic Laboratories   (United States)

Author keywords

Abortion; Autoimmunity; IVIG; Miscarriage; Natural killer cells

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ECTOPIC PREGNANCY; FEMALE; FEMALE INFERTILITY; HEADACHE; HUMAN; MATERNAL AGE; NATURAL KILLER CELL; NAUSEA; OUTCOMES RESEARCH; PREGNANCY COMPLICATION; PREGNANCY RATE; PREMATURE LABOR; PRIORITY JOURNAL; RECURRENT ABORTION; VOMITING;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; FEMALE; FERTILIZATION IN VITRO; HEADACHE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KARYOTYPING; KILLER CELLS; MATERNAL AGE; MIDDLE AGED; NAUSEA; OVARY; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PROSPECTIVE STUDIES; THYROID GLAND;

EID: 0033965814     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00572-5     Document Type: Article

References (38)

1. Stephenson M.D., Dreher K., Houlihan E., Wu V. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin a prospective, randomized, double-blinded, placebo-controlled trial . Am J Reprod Immunol. 39:1998;82-88.
2. Christiansen O.B. Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion the European experience . Am J Reprod Immunol. 39:1998;77-81.
3. Daya S., Gunby J., Clark D.A. Intravenous immunoglobulin therapy for recurrent spontaneous abortion a meta-analysis . Am J Reprod Immunol. 39:1998;69-76.
4. Balasch J., Creus M., Fabregues F., Font J., Martorell J., Vanrell J.A. Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertil Steril. 65:1996;655-658.
5. Templeton A., Morris J.K., Parslow W. Factors that affect outcome of in vitro fertilisation treatment. Lancet. 348:1996;1402-1406.
6. Gleicher N., Friberg J. IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters. JAMA. 253:1985;3278-3281.
7. Xu L., Chang V., Murphy A., Rock J.A., Barnewood M., Schlaff W. Antinuclear antibodies in sera of patients with recurrent pregnancy wastage. Am J Obstet Gynecol. 163:1990;1493-1497.
8. Stagnaro-Green A., Roman S.H., Cobin R.H., El-Harazy E., Alvarez-Marfany M., Davies T.F. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid antibodies. JAMA. 264:1990;1422-1425.
9. Maier D.B., Parke A. Subclinical autoimmunity in recurrent aborters. Fertil Steril. 51:1989;280-286.
10. Silver R.M., Branch D.W. Recurrent miscarriage autoimmune considerations . Clin Obstet Gynecol. 37:1994;745-760.
11. + cells can predict pregnancy outcome. Am J Reprod Immunol. 33:1995;40-46.
12. Hill J.A., Polgar K., Anderson D.J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA. 273:1995;1933-1936.
13. Lachapelle M.H., Miron P., Hemmings R., Roy D.C. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. J Immunol. 156:1996;4027-4034.
14. Haddad E.K., Duclos A.J., Lapp W.S., Baines M.G. Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua. J Immunol. 158:1997;4886-4891.
15. Rand J.R., Wu X.X., Andree H.A.M., Lockwood C.J., Guller S., Scher J. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med. 337:1997;154-160.
16. Blank M., Cohen J., Toder V., Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci USA. 88:1991;3069-3073.
17. Rosove M.H., Tabsh K., Wasserstrum N., Howard P., Hahn B.H., Kalunian K.C. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol. 75:1990;630-635.
18. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone . Am J Obstet Gynecol. 174:1996;1584-1589.
19. Lecuru F., Desnos M., Taurelle R. Anticoagulant therapy during pregnancy. Acta Obstet Gynecol Scand. 75:1996;217-221.
20. Pregnancy-related death associated with heparin and aspirin treatment for infertility, 1996. MMWR Morb Mortal Wkly Rep. 47:1998;368-371.
21. Laskin C.A., Bombardier C., Hannah M.E., Mandel F.P., Knox Ritchie J.W., Farewell V. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med. 337:1997;148-153.
22. Fraser E.J., Grimes D.A., Schulz K.F. Immunization as therapy for recurrent spontaneous abortion a review and meta-analysis . Obstet Gynecol. 82:1993;854-859.
23. Gafter U., Sredni B., Segal J., Kalechman Y. Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion. J Clin Immunol. 17:1997;408-419.
24. Coulam C.B., Stephenson M., Stern J.J., Clark D.A. Immunotherapy for recurrent pregnancy loss analysis of results from clinical trials . Am J Reprod Immunol. 35:1996;352-359.
25. Kiprov D.D., Nachtigall R.D., Weaver R.C., Jacobson A., Main E.K., Garovoy M.R. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol. 36:1996;228-234.
26. Coulam C.B., Krysa L.W., Bustillo M. Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod. 9:1994;2265-2269.
27. Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynecol. 101:1994;1072-1077.
28. Christiansen O.B., Mathieson O., Husth M., Rasmussen K.L., Ingerslev H.J., Lauritsen J.G. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod. 10:1995;2690-2695.
29. Jacobs D.S., Demott W.R., Grady H.J., Horvat R.T., Huestis D.W., Kasten B.L. Laboratory test handbook. 4th ed. 1996;Lexi-Comp, Hudson, OH.
30. Reid T.M.S. Striking a balance in maternal immune response to infection. [commentary] Lancet. 351:1998;1670-1671.
31. Piccinni M.P., Beloni L., Livi C., Maggi E., Scarselli G., Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med. 4:1998;1020-1024.
32. Sacks G., Sargent I., Redman C. An innate view of human pregnancy. Immunol Today. 20:1999;114-118.
33. Coulam C.B., Clark D.A. Immunotherapy for recurrent abortion. Am J Reprod Immunol. 32:1994;257-260.
34. Ruiz J.E., Kwak J.Y.H., Baum L., Gilman-Sachs A., Beaman K.D., Kim Y.B. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion. Am J Reprod Immunol. 35:1996;370-375.
35. Kwak J.Y.H., Kwak F.M.Y., Ainbinder S.W., Ruiz A.M., Beer A.E. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol. 35:1996;363-369.
36. Rigal D., Vermot-Desroches C., Heitz S., Bernaud J., Alfonsi F., Monier J.C. Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions specific effects on LFA-1 and CD56 molecules . Clin Immunol Immunopathol. 71:1994;309-314.
37. Prasad N.K.A., Papoff G., Zeuner A., Bonnin E., Kazatchkine M.D., Roberti G. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes a novel mechanism of action of IVIg involving the Fas apoptotic pathway . J Immunol. 161:1998;3781-3790.
38. Tsiatis A. Methodological issues in AIDS clinical trials. Intent-to-treat analysis. J AIDS. 3:(Suppl 2):1990;S120-S123.